Back

Baseline patient reported outcomes in patients with peripheral artery disease and type 2 diabetes from STRIDE: a phase 3, 52-week, randomised, double-blind, placebo-controlled trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Peripheral artery disease: risk factors Peripheral Artery Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

5 More presentations in this session

Presentation thumbnail
Cardiovascular risk factors in poly-vascular vs isolated lower extremity peripheral arterial disease. analysis from the SOLACI peripheral registry
Associate Professor L. Virgen Carrillo (Guadalajara, MX)
Abstract Slides Video
Presentation thumbnail
Natural language processing realises the potential of electronic health records: identifying risk factors for disease progression and major adverse limb events in intermittent claudication
Doctor J. Froud (London, GB)
Abstract Slides Video
Presentation thumbnail
Comparison of long-term prognosis between coronary artery disease and peripheral artery disease in haemodialysis and non-dialysis patients
Doctor Y. Kumada (Kasamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Evaluation of non-target lesions in femoropopliteal disease using near-infrared spectroscopy intravascular ultrasound imaging
Doctor Y. Sato (Fukui, JP)
Abstract Slides Video
Presentation thumbnail
Clinical impact of combined assessment of the CHADS2 score and geriatric nutritional risk index on clinical outcomes in patients with lower extremity artery disease without atrial fibrillation
Doctor N. Ito (Kagoshima, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: risk factors

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age
thumbnail
Congress Presentation
Developing a multi-center registry of peripheral artery disease using natural language processing: unlocking the power of the electronic health record
thumbnail
Congress Presentation
Three-year outcome after coronary stenting in all-comer patients: Impact of diabetes and peripheral arterial disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources